Acute myeloid leukaemia
A fast-growing cancer of the blood and bone marrow, in which the marrow makes large numbers of abnormal, immature white blood cells. It can cause tiredness, pale skin, shortness of breath, easy bleeding or bruising, and getting ill a lot. Treatment needs to start quickly and is mainly chemotherapy, sometimes with targeted medicines or a stem cell transplant. It can happen at any age, but it is more likely after 60, and the risk keeps rising with age.
Read more about acute myeloid leukaemiaTrial-stage treatments and research studies you can join
Filters
- Tests ziftomenib with standard drugs for untreated AML with certain gene changes
Tests ziftomenib with standard drugs in adults with new AML and certain genes.
Gdansk, PolandAlso Lublin, TorunAge 18+ - Tests bleximenib with chemotherapy in newly diagnosed acute myeloid leukemia
Tests bleximenib added to chemotherapy in adults with NPM1 or KMT2A gene changes.
Bialystok, PolandAlso Gdansk, Lodz, Warsaw, WroclawAge 18+ - Testing CHM-029 pill in adults with relapsed or hard-to-treat acute myeloid leukemia
Tests the new pill CHM-029 in adults with relapsed or hard-to-treat leukemia.
Lodz, PolandAlso Warsaw, WroclawAge 18+ - Continued Treatment and Safety Monitoring for People With Certain Cancers
Follows people with blood cancers and solid tumors who continue study drugs long term.
Gdansk, PolandAlso Katowice, SkorzewoAge 18+ - Tests bleximenib with venetoclax and azacitidine for newly diagnosed acute myeloid leukemia
Tests bleximenib with venetoclax and azacitidine in adults newly diagnosed with acute myeloid leukemia.
Bialystok, PolandAlso Bydgoszcz, Gdansk, Kielce, Lodz, WroclawAge 18+ - Tests mocravimod with stem cell transplant for acute myeloid leukemia
Tests mocravimod alongside transplant in adults with acute myeloid leukemia.
Gdansk, PolandAlso Katowice, Krakow, WarsawAge 18 to 75 - Tests revumenib with chemotherapy for newly diagnosed acute myeloid leukemia with NPM1 mutation
Tests revumenib added to chemotherapy in people aged 12 and older with newly diagnosed AML.
Bydgoszcz, PolandAlso Lublin, Olsztyn, WroclawAge 12+ - Tests oral ASTX030 alone or with venetoclax in myeloid blood cancers
Tests an oral form of azacitidine, alone or with venetoclax, in adults with blood cancers.
Gdynia, PolandAlso Lodz, LublinAge 18+ - Tests RVU120 with venetoclax in adults with relapsed or refractory acute myeloid leukemia
Tests RVU120 with venetoclax in adults whose acute myeloid leukemia returned after prior treatment.
Biała Podlaska, PolandAlso Gdansk, Katowice, Torun, Wałbrzych, Warsaw, Wroclaw, Zielona GóraAge 18+ - Continued RVU120 Treatment for Patients From an Earlier Study
Gives continued RVU120 treatment to adults from an earlier RVU120 study.
Chorzow, PolandAlso Gdansk, Katowice, Lublin, WroclawAge 18+ - Tests bezuclastinib in adults with advanced systemic mastocytosis
Tests bezuclastinib in adults with advanced systemic mastocytosis, a rare blood disease.
Lublin, PolandAge 18+ - Tests liposomal annamycin with cytarabine for returning acute myeloid leukemia
Tests annamycin with cytarabine in adults with relapsed or refractory acute myeloid leukemia.
Bialystok, PolandAlso Katowice, Olsztyn, Poznan, Torun, WarsawAge 18 to 80 - Continued ASTX727 treatment for people from earlier studies with blood cancers
Gives continued ASTX727 to adults with blood cancers who benefited from earlier studies.
Gdansk, PolandAlso WroclawAge 18+ - Tests a pill for cancer in people with severe kidney problems
Checks how the body handles oral decitabine and cedazuridine in adults with cancer.
Wroclaw, PolandAge 18+ - Tests an oral drug combination in cancer patients with liver problems
Checks how the body handles oral decitabine and cedazuridine in adults with liver damage.
Wroclaw, PolandAge 18+ - Tests lisaftoclax with azacitidine for newly diagnosed acute myeloid leukemia
Tests lisaftoclax with azacitidine against placebo in adults with newly diagnosed leukemia.
Warsaw, PolandAge 18+ - Tests tuspetinib in adults with relapsed or refractory acute myeloid leukemia
Tests tuspetinib, alone or with other drugs, in adults with acute myeloid leukemia.
Gdansk, PolandAlso Gdynia, WarsawAge 18+ - Gene-guided cladribine drug combinations for acute myeloid leukemia
Tests gene-guided cladribine combinations in people with acute myeloid leukemia.
Bialystok, PolandAlso Brzozów, Bydgoszcz, Chorzów, Gdansk, Gdynia, Lodz, Lublin, Poznan, …Age 18+ - Observes outcomes in people with relapsed or refractory acute myeloid leukemia
Follows people with acute myeloid leukemia that has returned or not responded to treatment.
Gdansk, PolandAge 6+ - Comparing two treatment intensities after leukemia or lymphoma shows no remaining disease
Compares standard and reduced intensity follow-up treatment in adults with AML or CLL.
Gdansk, PolandAlso Gliwice, Katowice, Lodz, Lublin, Warsaw, WroclawAge 18+
Where treatment stands
Approved: 34
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 32
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 5
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 2
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.
Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 209 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for acute myeloid leukaemia. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in Poland, for you and your family.
Acute myeloid leukaemia organisations in Poland
- Fundacja Carita im. Wieslawy Adamiec (Zyc ze Szpiczakiem)
Polish haemato-oncology patient foundation (origin in myeloma): free psychological support, patient Facebook group, patient taxi help, teleassistance for elderly patients, patient academies and HemaInfo education.
- Fundacja na Rzecz Pomocy Chorym na Bialaczki
Help for patients with blood cancers in haematology wards and clinic, free online educational workshops (leukaemias, lymphomas, myeloma), free e-book on blood diseases; contact form.
- Fundacja Urszuli Smok Podaruj Zycie
Support, information and advice for children and adults with leukaemia and blood diseases and their families, assistance programmes, fundraising accounts for treatment, patient guides.
- Polska Liga Walki z Rakiem
Polish cancer league (ECL member) building cooperation between health care, education, science and social policy to fight cancer and support patients.
- Stowarzyszenie Kierunek Zdrowie (Go for Health!)
Polish association for blood-cancer patients incl. myeloma: psychological and educational support, peer volunteer phone contacts by diagnosis, hospital ward support, rehabilitation retreats, conferences.
General support in Poland
- Centrum Wsparcia dla osób dorosłych w kryzysie psychicznym
Free 24/7 support line (800 70 2222) and chat for adults in psychological crisis in Poland, funded by the Ministry of Health.
- pacjent.gov.pl
Patient portal of the Polish Ministry of Health and National Health Fund with reliable, verified information on health and the care system.
- Rzecznik Praw Pacjenta
Poland's central government Patient Ombudsman protecting patient rights, with a free patient helpline (800 190 590).
International organisations
- DKMS
Finds blood stem cell donors worldwide so that people with blood cancer can have a transplant.
Offer tissue or data
There are three ways to help research move faster.
Treatments outside Poland
Medicines for acute myeloid leukaemia approved in the US or Japan that are not approved in Poland, nor anywhere else in the EU.
Checked on 11 Nov 2026 in the official lists of the US (FDA), Japan (PMDA, approvals since April 2004) and the EU (EMA). 6 uncertain matches are left out.
Your health insurer may pay part of the cost, sometimes all of it. This depends on your insurer, your plan and the country, so always ask your insurer before you go. For planned care in the EU, the EEA and Switzerland, ask about form S2.
“Miracle cure” fact checker
Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- CBD (cannabidiol) & Acute myeloid leukaemia
- Vitamin C (incl. high-dose) & Acute myeloid leukaemia
- Ivermectin & Acute myeloid leukaemia
- Fenbendazole & Acute myeloid leukaemia
About acute myeloid leukaemia
Sources: NHS, NCI PDQ, Cancer Research UK, The New England Journal of Medicine
A fast-growing cancer of the blood and bone marrow, in which the marrow makes large numbers of abnormal, immature white blood cells. It can cause tiredness, pale skin, shortness of breath, easy bleeding or bruising, and getting ill a lot. Treatment needs to start quickly and is mainly chemotherapy, sometimes with targeted medicines or a stem cell transplant. It can happen at any age, but it is more likely after 60, and the risk keeps rising with age.
What is it?
AML is a rare cancer of the blood and bone marrow. Bone marrow, found in the centre of most bones, makes blood cells. In AML it makes large numbers of abnormal, immature white blood cells that crowd out the healthy ones. It is the most common type of acute leukaemia in adults. 'Acute' means it gets worse quickly, so treatment needs to start fast.
It can happen at any age, but it is more likely after 60. Being male may also raise the risk. The risk is also higher if you smoke, had chemotherapy or radiotherapy in the past, have another blood disorder, have a genetic condition such as Down's syndrome, or were often exposed to high levels of the chemical benzene. It is not always clear what causes it.
The first signs
The signs are often not obvious at first and can feel like flu. They usually come on quickly, over a few weeks:
- feeling very tired or weak;
- looking paler than usual (on brown or black skin, check the palms or the inside of the eyelids);
- getting out of breath;
- bleeding or bruising easily;
- a high temperature, or getting ill a lot or taking longer than usual to recover from illnesses;
- aching bones or joints, a swollen tummy or swollen glands.
They can be caused by many other conditions, but they need checking.
How doctors find out
Your family doctor usually arranges an urgent blood test, and may send you to a hospital specialist or straight to hospital. The main tests are blood tests and a bone marrow biopsy: a small sample of marrow is taken with a needle from the hip bone or breastbone, usually after numbing the skin. Gene tests on the leukaemia cells help choose the treatment. You may also need a lumbar puncture (a little fluid taken from the lower back) and scans. Blood results can come within a few days; other tests take a few weeks.
Current treatment
Intensive chemo, sometimes a stem cell transplant
Will it get worse?
Without treatment, AML gets worse quickly, but it is often treatable. How serious it is depends on the type of AML, your age and your general health. In older people, the leukaemia may be less likely to go into remission. Even after remission, the leukaemia can come back, which is why treatment carries on afterwards. When AML cannot be cured, treatment aims to control it, ease symptoms and help you live longer.
Medicines: what helps, and what to watch for
Chemotherapy is the main treatment, usually several medicines together. Intensive treatment aims to cure the leukaemia and is usually given in hospital. Non-intensive treatment aims to control it for as long as possible; it is usually given at home and has fewer side effects. Targeted medicines can be added, for example when the leukaemia has a change in the FLT3 gene. One type, acute promyelocytic leukaemia, may be treated with ATRA and arsenic trioxide.
Good to know:
- Treatment comes in phases: first to clear the leukaemia from the blood and marrow, then more treatment to kill any cells that are left;
- AML and chemotherapy lower your blood counts, so you are watched closely and may need blood and platelet transfusions;
- You may get antibiotics and antifungal medicines to prevent or treat infections;
- You have regular check-ups, tests and scans during and after treatment;
Exercise and diet help too
Tiredness is one of the most common problems and can continue for months after treatment. After treatment, exercise can help your body and your mood: start gently, for example with walking, and build up slowly. You can go swimming once your white blood cell count is back to normal and you no longer have a central line. A good, balanced diet might help you feel stronger and recover more quickly. Your nurse can refer you to a dietitian or a physiotherapist.
- After a stem cell transplant, your team may give you food-safety advice for the first few months, such as eating only freshly cooked food;
A transplant, for some people
A stem cell or bone marrow transplant replaces the damaged blood-making cells with healthy ones. First you get high-dose chemotherapy, sometimes with radiotherapy, and then the stem cells are given back to you through an infusion. They can be your own cells or come from a donor. It may be offered if the leukaemia is likely to come back, has come back, or other treatments are not working.
Is there a cure?
Sometimes. Intensive treatment aims to cure AML, and more than 1 in 4 adults live 3 years or more and may be cured. For others, treatment aims to keep it under control. New treatments are being tested in clinical trials.
Median survival
About 15 months with azacitidine and venetoclax, for people who cannot have intensive chemotherapy
Measured in: Previously untreated AML in people who could not have intensive chemotherapy (median age 76): the VIALE-A trial (431 patients)
The figures behind it
VIALE-A (431 previously untreated patients who were ineligible for intensive chemotherapy, median age 76): median overall survival 14.7 months with azacitidine plus venetoclax vs 9.6 months with azacitidine alone. People who can have intensive chemotherapy are not part of this figure.
Sources
Written in plain words by Frontlight from these pages:
- NCI PDQ: Acute Myeloid Leukemia Treatment (PDQ®) – Patient Version
- NHS: Acute myeloid leukaemia – Symptoms
- NHS: Acute myeloid leukaemia – Treatment
- NHS: Acute myeloid leukaemia – What is AML?
- NHS: Acute myeloid leukaemia – Causes
- NHS: Acute myeloid leukaemia – Tests and next steps
- Cancer Research UK (charity): Coping with acute myeloid leukaemia
- Cancer Research UK (charity): Diet and physical activity after AML
- NCI PDQ: Adult Acute Myeloid Leukemia Treatment (PDQ®) – Health Professional Version
- The New England Journal of Medicine: Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia